Evidence map›Paper›PMID 31649166›Full record

ArticleScience (New York, N.Y.)2019

MAIT cells are imprinted by the microbiota in early life and promote tissue repair.

Michael G Constantinides, Verena M Link, Samira Tamoutounour, Andrea C Wong, P Juliana Perez-Chaparro, Seong-Ji Han, Y Erin Chen, Kelin Li, Sepideh Farhat, Antonin Weckel and 13 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 342 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
342citing papers in PubMed, 1 pooled it
22.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

342 citing papers in PubMed, 1 synthesis or guideline pooled it, 544 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Gut archaea drive human MAIT cell responses.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Select intratumoral riboflavin-auxotrophicProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

282 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 1 country.

Michael G ConstantinidesMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-4770-7751
Verena M LinkMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-3207-312X
Samira TamoutounourMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Andrea C WongImmunology Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-3373-417X
P Juliana Perez-ChaparroNIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-7430-6449
Seong-Ji HanMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Y Erin ChenDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.
Kelin LiDivision of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-8630-2928
Sepideh FarhatDepartment of Dermatology, University of California, San Francisco, CA 94143, USA.
Antonin WeckelDepartment of Dermatology, University of California, San Francisco, CA 94143, USA.ORCID 0000-0002-5085-0551
Siddharth R KrishnamurthyMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-1777-8292
Ivan Vujkovic-CvijinMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-8611-4900
Jonathan L LinehanMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-2862-0511
Nicolas BouladouxMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-1593-671X
E Dean MerrillMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-7175-5046
Sobhan RoyDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-3511-7869
Daniel J CuaMerck & Co., Merck Research Laboratories, Palo Alto, CA 94304, USA.
Erin J AdamsDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-6271-8574
Avinash BhandoolaLaboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-4657-8372
Tiffany C ScharschmidtDepartment of Dermatology, University of California, San Francisco, CA 94143, USA.
Jeffrey AubéDivision of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0003-1049-5767
Michael A FischbachDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-3079-8247
Yasmine BelkaidMetaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. ybelkaid@niaid.nih.gov.ORCID 0000-0001-9962-3571
National Institutes of Health · USUniversity of California, San Francisco · USStanford University · USUniversity of Chicago · USUniversity of North Carolina at Chapel Hill · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Pennsylvania · US

Funding

Viable but Nonculturable MtbU19AI111143 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GLICKMAN, MICHAEL S, RHEE, KYU Y · 2014 to 2020
$48.6M
Role of the microbiota in immunityZIAAI001115 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2009 to 2025
$22.4M
Role of Tissue-Specific Factors in the Control of ImmunityZIAAI001132 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2011 to 2025
$6.4M
A complete map of the top 100 molecules from the gut microbiomeDP1DK113598 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2020
$5.5M
Decoding and harnessing microbial tuning of T cell responses in early lifeDP2AI144968 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHARSCHMIDT, TIFFANY CRAWFORD · 2018 to 2018
$2.4M
Identification and characterization of natural products from the human microbiotaR01DK110174 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2019
$1.4M
Elucidating mechanisms of tolerance to commensal skin bacteriaK08AR068409 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHARSCHMIDT, TIFFANY CRAWFORD · 2015 to 2019
$851k
Howard Hughes Medical InstituteIntramural NIH HHS ZIA AI001115Intramural NIH HHS ZIA AI001132NIAID NIH HHS DP2 AI144968NIAID NIH HHS U19 AI111143NIAID NIH HHS ZIA AI001115NIAID NIH HHS ZIA AI001132NIAMS NIH HHS K08 AR068409NIDDK NIH HHS DP1 DK113598NIDDK NIH HHS R01 DK110174
6 · The paper itself

Abstract

How early-life colonization and subsequent exposure to the microbiota affect long-term tissue immunity remains poorly understood. Here, we show that the development of mucosal-associated invariant T (MAIT) cells relies on a specific temporal window, after which MAIT cell development is permanently impaired. This imprinting depends on early-life exposure to defined microbes that synthesize riboflavin-derived antigens. In adults, cutaneous MAIT cells are a dominant population of interleukin-17A (IL-17A)-producing lymphocytes, which display a distinct transcriptional signature and can subsequently respond to skin commensals in an IL-1-, IL-18-, and antigen-dependent manner. Consequently, local activation of cutaneous MAIT cells promotes wound healing. Together, our work uncovers a privileged interaction between defined members of the microbiota and MAIT cells, which sequentially controls both tissue-imprinting and subsequent responses to injury.

Indexed as

AnimalsBacteriaGerm-Free LifeHistocompatibility Antigens Class IHumansInterleukin-1Interleukin-17Interleukin-18Interleukin-23MiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMicrobiotaMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsHistocompatibility Antigens Class IIL17A protein, humanIL18 protein, humanInterleukin-1Interleukin-17Interleukin-18Interleukin-23Minor Histocompatibility AntigensMr1 protein, mouseRiboflavin

Identifiers

PMID31649166
PMCPMC7603427
OpenAlexW2981494076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.